Related Experiment Video
Updated: May 30, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Published on: January 5, 2016
Immune correlates of HIV control
J G Prado1, J Carrillo, J Blanco-Heredia
1AIDS Research Institute IrsiCaixa - HIVACAT, Hospital Germans Trias i Pujol, Badalona, Spain.
Identifying reliable immune markers for HIV control remains a challenge. This review examines host genetics and immune responses, focusing on T cells and antibodies, to find direct correlates for effective HIV vaccine development.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- Developing an effective HIV vaccine is hindered by the absence of clear immune correlates for viral control.
- Previous studies identified immune markers associated with slower HIV progression, but causality remains uncertain.
- These markers may act collectively or indicate controlled infection rather than direct control mechanisms.
Purpose of the Study:
- To review current knowledge on host genetic and immune markers associated with HIV control.
- To specifically examine the role of virus-specific T cells and humoral immune responses.
- To evaluate these immune responses as direct correlates of HIV control.
Main Methods:
- Literature review of existing research on host factors and HIV control.
- Analysis of studies investigating T cell and antibody responses in HIV infection.
- Assessment of evidence linking immune markers to viral load and disease progression.
Main Results:
- Host genetic factors and immune responses are linked to HIV control, but direct causal relationships are often unclear.
- Virus-specific T cells and humoral immunity show potential as correlates of control.
- The complexity of immune interactions and potential for surrogate markers complicate definitive conclusions.
Conclusions:
- Further research is needed to establish definitive immune correlates for HIV control.
- Understanding T cell and antibody functions is crucial for designing effective HIV vaccines.
- Clarifying the causality of immune markers will advance HIV vaccine development efforts.
More Related Videos
09:26In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
14:23A Restriction Enzyme Based Cloning Method to Assess the In vitro Replication Capacity of HIV-1 Subtype C Gag-MJ4 Chimeric Viruses
Published on: August 31, 2014
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Retrovirus Life Cycles
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Inhibitors of Virion Maturation and Assembly